Category: SRS Fund
-
DBS 2024 Annual Report Breakdown

DBS had a standout year in 2024, achieving record-breaking financial performance, deepening its digital transformation, and strengthening its commitment to sustainability and community impact.
-
The SRS Fund Feb 2025

As we head towards the end of the current government term, Singapore was pleasantly surprised with a budget surplus as its economy grew by 4.4% in 2024.
-
The SRS Fund Jan 2025

As the new US president gets to work. The world is anticipating his policies that will likely impact many businesses and countries.
-
MyNest US Fund Jan 25

2025 started with a furry of news and activities that may have further implacations on companies in the portfolio. The 2 key events I kept my eyes on was the following.
-
Jumbo Group Annual Report Review

Jumbo group was a position initiated into the SRS Fund due to my revenge travel boom thesis in Jun 2023. Back then I concluded that Jumbo is well positioned to take advantage of Singapore’s reopening to tourism. 18 months later, business was indeed brisk
-
MyNest US Fund Launch

I started investing in the US Stock Market in 2021. Over a 4 year period, I have accumulated good investing experience and achieved some success in the US market.
-
The SRS Fund Dec 2024 Update

The SRS Fund had its best return in a year since its inception in 2024. SRS Fund value was up 19.4%, excluding new contributions. However, the SRS Fund underperformed its benchmark STI index which drums up a whopping 22% (Dividend included).
-
The SRS Fund Nov 2024 Update

The US Presidential Election took centre stage for the month of November. Global stocks then rallied on the back of Donald Trump’s return to the white house. The euphoria took place across all asset classes, led by crypto, as bitcoin rallied past the 100k mark.
-
The SRS Fund Oct 2024 Update

As the enthusiasm for the Fed interest rate cut and announced China stimulus subsided during October, the focus has now turned to upcoming earnings seasons.
-
The SRS Fund Sep 2024 Update

In last month’s review, I pointed out that the STI benchmark will be hard to beat going forward and any outperformance of the SRS fund will likely be contributed by our China-related holdings.
